Delivery Order HHSN261201300029I-HHSN26100003

Award Date 2/16/16
Potential Completion Date 9/30/19
Potential Value $128K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to PPD Development LP, a global contract research organization (CRO), by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH). The contract has an award value of $15,924,990.66 and is for the NCI's Cancer Trials Support Unit (CTSU) program, which provides administrative and other support services. The contract is a delivery order under a larger master IDIQ contract. There is no set-aside designation for this award. As a CRO,...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, valued at $66,339,562.95, is for the TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER and has a performance period ending on February 23, 2023. PPD Development LP, a subsidiary of Thermo Fisher...
This is a $1,859,402 task order award under the National Institute of Allergy and Infectious Diseases' (NIAID) Early Phase Clinical Trial Units (EPCTU) indefinite delivery vehicle (IDV) contract. The prime contractor, PPD Development LP, is a global contract research organization that provides comprehensive clinical trial and research support services to federal agencies. This cost-plus-fixed-fee delivery order does not have a set-aside designation. PPD will perform the work in Cape Fear,...
This federal contract award is for regulatory consulting assistance and research and development for clinical studies in the Blueprint MedTech program, which is managed by the National Institute on Drug Abuse (NIDA), a civilian agency. The award was made to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract has a period of performance from September 15, 2023 to September 14, 2024, with a ceiling value of $64,107.00. This...
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PPD Development LP, a global contract research organization. The contract has a value of $347,500.00 and is a delivery order under the CRO Support for NCATS Bioanalytical Method Development Indefinite Delivery Contract (IDC). The contract provides clinical trial and research support services, including areas such as...
This is a cost-plus-fixed-fee definitive contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO), for R&D services related to biomedical basic research. The $27,437,431.92 contract has a performance period ending on October 31, 2021 and is not set aside for any specific business type. PPD Development LP has been awarded over $500 million in prime federal...
This is a $1,299,218 definitive contract awarded by the Food and Drug Administration (FDA) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract is for "BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS" and has a completion date of February 2, 2026. The contract is a Time and Materials type with no set-aside designation. As a CRO, PPD...
This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The $18,792,842.54 contract is for the Immune Tolerance Network - Clinical Site Monitoring Group, which involves comprehensive clinical trial and research support services such as regulatory affairs, clinical site monitoring,...
This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to PPD Development LP for NIAID Clinical Site Monitoring services. The contract has a ceiling value of $140,719,763.00 and a period of performance ending on January 31, 2024. PPD Development LP is a global contract research organization (CRO) that provides clinical trial and research support services to federal...
This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is not...

This federal contract award from the National Cancer Institute (NCI) is a delivery order under the NIH Cancer Trials Support Unit (CTSU) Indefinite Delivery Vehicle (IDV). The $128,414.63 award was issued to PPD Development LP, a global contract research organization (CRO) that provides comprehensive clinical trial and research support services to federal agencies.

The contract supports the Cancer Trials Support Unit program, which provides clinical trial management and research services to advance cancer research and medical countermeasures. As a subsidiary of Thermo Fisher Scientific, PPD Development LP has a strong track record of delivering specialized services for federal agencies across areas such as regulatory affairs, site monitoring, data management, and analytical testing. This award demonstrates PPD's capabilities in supporting complex clinical studies and research programs for the NCI.

Generated 4/3/25, 12:45 AM